ConductScience.org, home

Paper20814331

Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.

Novalbos J and 5 others. J Clin Psychopharmacol, 2010. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. Papers, record 20814331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20814331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.
PubMed
Journal
J Clin Psychopharmacol
PubMed
Year
2010
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Novalbos JJesús
2López-Rodríguez RRosario
3Román MManuel
4Gallego-Sandín SSonia
5Ochoa DDolores
6Abad-Santos FFrancisco

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 CYP2D6Major topic
Polymorphism, GeneticMajor topic
RisperidoneMajor topic
Adult
Alleles
Cross-Over Studies
Dizziness
Female
Genetic Variation
Genotype
Headache
Humans
Male
Young Adult

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in21449670Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions.https://conductscience.org/library/papers/21449670

Source PubMed

Download CSV of comments and corrections

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
40116580Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review.Pharmacogenomics2025https://conductscience.org/library/papers/40116580PubMed
39832006Validating the accuracy of mathematical model-based pharmacogenomics dose prediction with real-world data.Eur J Clin Pharmacol2025https://conductscience.org/library/papers/39832006PubMed
39505757Synergistic Epistasis and Systems Biology Approaches to Uncover a Pharmacogenomic Map Linked to Pain, Anti-Inflammatory and Immunomodulating Agents (PAIma) in a Healthy Cohort.Cell Mol Neurobiol2024https://conductscience.org/library/papers/39505757PubMed
38375040Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism.Front Pharmacol2024https://conductscience.org/library/papers/38375040PubMed
36655374Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate.Clin Transl Sci2023https://conductscience.org/library/papers/36655374PubMed
36597259CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.Expert Opin Drug Metab Toxicol2022https://conductscience.org/library/papers/36597259PubMed
36015360Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone.Pharmaceutics2022https://conductscience.org/library/papers/36015360PubMed
34575384Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders.J Clin Med2021https://conductscience.org/library/papers/34575384PubMed
34335273Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone.Front Pharmacol2021https://conductscience.org/library/papers/34335273PubMed
33352925Application of a Pharmacogenetics-Based Precision Medicine Model (5SPM) to Psychotic Patients That Presented Poor Response to Neuroleptic Therapy.J Pers Med2020https://conductscience.org/library/papers/33352925PubMed
32015455The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis.Pharmacogenomics J2020https://conductscience.org/library/papers/32015455PubMed
31359271Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes.Clin Pharmacokinet2020https://conductscience.org/library/papers/31359271PubMed
30661084CYP2D6 genotype and adverse events to risperidone in children and adolescents.Pediatr Res2019https://conductscience.org/library/papers/30661084PubMed
29181698Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.Eur J Clin Pharmacol2018https://conductscience.org/library/papers/29181698PubMed
29099060Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.J Pers Med2017https://conductscience.org/library/papers/29099060PubMed
28512322Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine.Sci Rep2017https://conductscience.org/library/papers/28512322PubMed
28165818Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique.Drug Deliv2017https://conductscience.org/library/papers/28165818PubMed
27942231CYP2D6 polymorphisms and their influence on risperidone treatment.Pharmgenomics Pers Med2016https://conductscience.org/library/papers/27942231PubMed
26937359Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort.Appl Transl Genom2015https://conductscience.org/library/papers/26937359PubMed
26129906Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.Clin Pharmacokinet2015https://conductscience.org/library/papers/26129906PubMed

See all 23 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20814331

GET https://conductscience.org/api/papers/v1/20814331/cited_by?page=2